« To Hold or Not to Hold? Periprocedural Management of Glucagon-Like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients With Diabetes and Obesity ». Canadian Diabetes & Endocrinology Today 4, no. 1 (mai 25, 2026): 26–34. Consulté le mai 26, 2026. https://CanadianDiabetesAndEndocrinologyToday.com/article/view/4-1-Khan.